Szpital Specjalistyczny W Chorzowie
Chorzów, Poland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 32 346 36 15
- Websitehttps://sswch.pl/
About this provider
Szpital Specjalistyczny w Chorzowie is a public specialist hospital in Chorzów, Silesia, that runs a Mental Health Center (CZP) alongside its other departments. Per NFZ data it provides program B.147 — fully funded esketamine (Spravato) treatment for treatment-resistant depression — with no queue reported as of June 2026. Its own pages describe a 40-bed, coeducational 24-hour psychiatric ward staffed by psychiatrists, psychologists, psychotherapists, an occupational therapist and a social worker, plus a day psychiatric ward; inpatient admission follows psychiatric assessment with a doctor's referral.
Services & programs
- 24-hour psychiatric ward (40 beds, coeducational)
- Day psychiatric ward
- Mental Health Center (CZP) for adults
- Psychiatric qualification assessment in the hospital admission room
- Occupational therapy and social-work support within the psychiatric ward
Common questions
How do I get into the NFZ esketamine program at this center?
Ask your doctor for a referral and contact the hospital's psychiatric service (registration +48 32 346 36 70). The center's psychiatrists qualify patients under NFZ program B.147: adults aged 18-75 with moderate-to-severe depression that has not responded to at least two antidepressants.
What does the treatment cost?
Nothing for insured patients — program B.147 is fully funded by the NFZ. The esketamine nasal spray is administered at the center under medical supervision, alongside an oral antidepressant prescribed by the program physician.
How long does the program last?
Treatment under the program lasts up to 34 weeks, with dosing visits more frequent at the start and then spaced out according to clinical response.
Verification
- License / registryNFZ B.147
- Sourcehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Last verified